AML is not a single disease. It is a group of leukemias that develop in the bone marrow from progenitors
A new Achilles’ heel of blood cancer: New potential target identified to fight acute myeloid leukemia
Malaria parasite accumulates undetected in bone marrow
A Plasmodium vivax infection is like an iceberg: It’s dangerous, in part, because much of it hides out of view.
Protein responsible for leukemia’s aggressiveness identified
Researchers have identified a protein critical for the aggressiveness of T-cell leukemia, a subtype of leukemia that afflicts children and
Long-sought structure of telomerase paves way for new drugs for aging, cancer: Cryo-electron microscopy images reveal details of protein, RNA binding and possible drug-target sites
More than 30 years ago, when University of California, Berkeley researchers discovered telomerase — an enzyme that lengthens chromosome ends
Gene mapping lays groundwork for precision chemotherapy: First-of-its-kind study maps links between 625 genes and 31 different chemotherapy treatments
Despite the great successes of targeted cancer drugs and the promise of novel immunotherapies, the vast majority of people diagnosed
Chip-based blood test for multiple myeloma could make bone biopsies a relic of the past
The diagnosis and treatment of multiple myeloma, a cancer affecting plasma cells, traditionally forces patients to suffer through a painful
Uncovering a mechanism causing chronic graft-vs-host disease after bone marrow transplant
Allogeneic bone marrow transplant (BMT) is an essential treatment to cure patients with blood cancers such as leukemia. In patients
Pediatric cancer drug shows 93 percent response rate
A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric